100 related articles for article (PubMed ID: 11032420)
1. Novel nonpeptidic inhibitors of peptide deformylase.
Jayasekera MM; Kendall A; Shammas R; Dermyer M; Tomala M; Shapiro MA; Holler TP
Arch Biochem Biophys; 2000 Sep; 381(2):313-6. PubMed ID: 11032420
[TBL] [Abstract][Full Text] [Related]
2. Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
Apfel C; Banner DW; Bur D; Dietz M; Hirata T; Hubschwerlen C; Locher H; Page MG; Pirson W; Rossé G; Specklin JL
J Med Chem; 2000 Jun; 43(12):2324-31. PubMed ID: 10882358
[TBL] [Abstract][Full Text] [Related]
3. 2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors.
Apfel C; Banner DW; Bur D; Dietz M; Hubschwerlen C; Locher H; Marlin F; Masciadri R; Pirson W; Stalder H
J Med Chem; 2001 Jun; 44(12):1847-52. PubMed ID: 11384231
[TBL] [Abstract][Full Text] [Related]
4. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
Calí P; Naerum L; Mukhija S; Hjelmencrantz A
Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial activity of peptide deformylase inhibitors.
Huntington KM; Yi T; Wei Y; Pei D
Biochemistry; 2000 Apr; 39(15):4543-51. PubMed ID: 10758004
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of bacterial peptide deformylase by biaryl acid analogs.
Green BG; Toney JH; Kozarich JW; Grant SK
Arch Biochem Biophys; 2000 Mar; 375(2):355-8. PubMed ID: 10700392
[TBL] [Abstract][Full Text] [Related]
7. Novel approaches to antimicrobial therapy: peptide deformylase.
Waller AS; Clements JM
Curr Opin Drug Discov Devel; 2002 Sep; 5(5):785-92. PubMed ID: 12630299
[TBL] [Abstract][Full Text] [Related]
8. Peptide deformylase as an antibacterial drug target: target validation and resistance development.
Apfel CM; Locher H; Evers S; Takács B; Hubschwerlen C; Pirson W; Page MG; Keck W
Antimicrob Agents Chemother; 2001 Apr; 45(4):1058-64. PubMed ID: 11257016
[TBL] [Abstract][Full Text] [Related]
9. Peptide deformylase as an antibacterial drug target: assays for detection of its inhibition in Escherichia coli cell homogenates and intact cells.
Apfel CM; Evers S; Hubschwerlen C; Pirson W; Page MG; Keck W
Antimicrob Agents Chemother; 2001 Apr; 45(4):1053-7. PubMed ID: 11257015
[TBL] [Abstract][Full Text] [Related]
10. Purification, characterization, and inhibition of peptide deformylase from Escherichia coli.
Rajagopalan PT; Datta A; Pei D
Biochemistry; 1997 Nov; 36(45):13910-8. PubMed ID: 9374870
[TBL] [Abstract][Full Text] [Related]
11. Peptide aldehyde inhibitors of bacterial peptide deformylases.
Durand DJ; Gordon Green B; O'Connell JF; Grant SK
Arch Biochem Biophys; 1999 Jul; 367(2):297-302. PubMed ID: 10395747
[TBL] [Abstract][Full Text] [Related]
12. Novel 3-amino-2-hydroxy acids containing protease inhibitors. Part 1: Synthesis and kinetic characterization as aminopeptidase P inhibitors.
Stöckel-Maschek A; Stiebitz B; Koelsch R; Neubert K
Bioorg Med Chem; 2005 Aug; 13(16):4806-20. PubMed ID: 15993089
[TBL] [Abstract][Full Text] [Related]
13. Macrolactin N, a new peptide deformylase inhibitor produced by Bacillus subtilis.
Yoo JS; Zheng CJ; Lee S; Kwak JH; Kim WG
Bioorg Med Chem Lett; 2006 Sep; 16(18):4889-92. PubMed ID: 16809037
[TBL] [Abstract][Full Text] [Related]
14. N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity.
Hackbarth CJ; Chen DZ; Lewis JG; Clark K; Mangold JB; Cramer JA; Margolis PS; Wang W; Koehn J; Wu C; Lopez S; Withers G; Gu H; Dunn E; Kulathila R; Pan SH; Porter WL; Jacobs J; Trias J; Patel DV; Weidmann B; White RJ; Yuan Z
Antimicrob Agents Chemother; 2002 Sep; 46(9):2752-64. PubMed ID: 12183225
[TBL] [Abstract][Full Text] [Related]
15. Phosphinate, sulfonate, and sulfonamidate dipeptides as potential inhibitors of Escherichia coli aminopeptidase N.
Yang KW; Golich FC; Sigdel TK; Crowder MW
Bioorg Med Chem Lett; 2005 Dec; 15(23):5150-3. PubMed ID: 16168644
[TBL] [Abstract][Full Text] [Related]
16. Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species.
Smith KJ; Petit CM; Aubart K; Smyth M; McManus E; Jones J; Fosberry A; Lewis C; Lonetto M; Christensen SB
Protein Sci; 2003 Feb; 12(2):349-60. PubMed ID: 12538898
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of a macrocyclic inhibitor for peptide deformylase.
Hu X; Nguyen KT; Verlinde CL; Hol WG; Pei D
J Med Chem; 2003 Aug; 46(18):3771-4. PubMed ID: 12930137
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the design of antibiotics targeting peptide deformylase.
Hao B; Gong W; Rajagopalan PT; Zhou Y; Pei D; Chan MK
Biochemistry; 1999 Apr; 38(15):4712-9. PubMed ID: 10200158
[TBL] [Abstract][Full Text] [Related]
19. 2D-QSAR in hydroxamic acid derivatives as peptide deformylase inhibitors and antibacterial agents.
Gupta MK; Mishra P; Prathipati P; Saxena AK
Bioorg Med Chem; 2002 Dec; 10(12):3713-6. PubMed ID: 12413827
[TBL] [Abstract][Full Text] [Related]
20. Hydroxamic acids as potent inhibitors of Fe(II) and Mn(II) E. coli methionine aminopeptidase: biological activities and X-ray structures of oxazole hydroxamate-EcMetAP-Mn complexes.
Huguet F; Melet A; Alves de Sousa R; Lieutaud A; Chevalier J; Maigre L; Deschamps P; Tomas A; Leulliot N; Pages JM; Artaud I
ChemMedChem; 2012 Jun; 7(6):1020-30. PubMed ID: 22489069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
